(NASDAQ: DRTS) Alpha Tau Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.89%.
Alpha Tau Medical's earnings in 2025 is -$31,750,000.On average, 3 Wall Street analysts forecast DRTS's earnings for 2025 to be -$33,550,418, with the lowest DRTS earnings forecast at -$34,486,479, and the highest DRTS earnings forecast at -$33,078,868. On average, 3 Wall Street analysts forecast DRTS's earnings for 2026 to be -$33,311,124, with the lowest DRTS earnings forecast at -$35,190,285, and the highest DRTS earnings forecast at -$32,375,062.
In 2027, DRTS is forecast to generate -$24,281,297 in earnings, with the lowest earnings forecast at -$25,337,005 and the highest earnings forecast at -$23,225,588.